Alto Neuroscience, Inc. · NYSE:ANRO
Point72 Asset Management, L.P.'s stake in Alto Neuroscience, Inc. fell to 3.70% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Point72 Asset Management, L.P.'s stake in Alto Neuroscience, Inc. fell to 3.70%, 1,170,865 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 3.70%
- Shares
- 1,170,865
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 1.60% | 503,087 |
| Point72 Capital Advisors, Inc. | 1.60% | 503,087 |
| Point72 Biotech Private Investments, LLC | 2.10% | 667,778 |
| Differentiated Ventures Investments, LLC | 2.10% | 667,778 |
| 72 Investment Holdings, LLC | 2.10% | 667,778 |
| Steven A. Cohen | 3.70% | 1,170,865 |
Source
Related
- Alto Neuroscience, Inc.
- Point72 Asset Management, L.P.
- Alto Neuroscience, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 14, 2025
- Form 4 · Smith Nicholas Conrad · Oct 5, 2026
- Form 4 · Smith Nicholas Conrad · Oct 1, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026